The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant Health
NCT07559773 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2026-04-30
Summary
The 'Standard of Care Plus' ('PLUS') model in the ROOT Study consists of analyzing select micronutrient and gene variants of pregnant females to construct trimester-specific and personalized nutrition and lifestyle recommendations in collaboration with in-person standard obstetric care (SOC).
In 2014, the investigators demonstrated statistically significant reductions in adverse maternal and infant outcomes using the 'PLUS' model compared to SOC alone. Further study in a 50% Medicaid Oregon 'PLUS' cohort (N=387) demonstrated association with highly significant risk reductions in all primary outcomes (p-value \<0.001): preterm birth: relative risk (RR) = 0.238 (4.2x less likely), hypertensive disorders of pregnancy: RR = 0.229 (4.4x less likely), gestational diabetes: RR = 0.071 (14x less likely), small for gestational age: RR = 0.252 (4x less likely), and large for gestational age: RR = 0.357 (2.8x less likely). A 100% Medicaid and ethnically diverse Nevada 'PLUS' cohort showed similar trends in all outcomes that were not statistically significant because of small sample size.
Structured as a prospective interventional study, the study evaluates whether the 'PLUS' model can achieve similar outcome improvements within the Novant Health (NH) system in North Carolina. The study will assess both clinical outcomes and digital nutrition platform performance within the existing healthcare infrastructure.
The primary hypothesis of the ROOT study is that collaborative implementation of the 'PLUS' nutritional care model at NH Triad Obstetrics/Gynecology (OB/GYN) Clinic will be associated with reduced maternal and infant adverse outcome rates when compared to historical regional and NH system outcomes in those who received SOC alone.
The secondary hypothesis of the ROOT Study is that the 'PLUS' model applied during pregnancy will be associated with reduced pediatric adverse outcomes. The 'PLUS' offspring that remain in the NH system will be observed longitudinally over 5 years with chart review at birth through 2 weeks of age, and at 1, 3, and 5 years of life. The outcomes assessed include neonatal intensive care unit (NICU) admission in the first two weeks of life, atopic dermatitis, eczema, asthma, allergies, otitis media, obesity, and autism. The 'PLUS' adverse outcome rates will be compared to adverse outcome rates in children born regionally and nationally under SOC alone.
Participant compliance with the 'PLUS' model, and participant and nutritionist access to the digital health platform will be studied during each trimester of use, as well as in the postpartum time period. The exploratory hypothesis is that the digital platform will not affect access, compliance, and rates of maternal and neonatal adverse outcomes.
Conditions
- Preterm Birth
- Preeclampsia
- Gestational Diabetes Mellitus (GDM)
- Small for Gestational Age (SGA)
- Large for Gestational Age (LGA)
- Asthma Childhood
- Atopic Dermatitis
- Autism
- Otitis Media Recurrent
- Obesity
Interventions
- OTHER
-
'Standard of Care PLUS'
All pregnant patients presenting to the sponsoring clinic will receive standard obstetric care. Those patients who meet inclusion criteria and agree to participate will receive standard obstetric care 'PLUS' select micronutrient and gene variant evaluation allowing creation of customized nutrition and lifestyle plans with targeted micronutrient supplementation. The plans will be modified in each trimester and postpartum to meet the physiologic demands specific to the time period. Serum micronutrient levels, nutrition/lifestyle plan adherence, and micronutrient supplementation adherence will be re-evaluated in each subsequent trimester and in the postpartum time period allowing individual adjustment. The 'PLUS' model will be delivered virtually via a digital nutrition health platform.
Sponsors & Collaborators
-
GrowBaby Life Project
lead OTHER
Principal Investigators
-
Leslie P Stone, MD · GrowBaby Health
-
Lewis Lipscomb, MD · Novant Health Triad OB/Gyn Clinic
-
Emily S Rydbom, MS · GrowBaby Health, GrowBaby Life Project
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-31
- Primary Completion
- 2028-12-31
- Completion
- 2033-12-31
More Related Trials
-
Mother Infant Nutrition Study
NCT04132310 ·Status: ENROLLING_BY_INVITATION
-
Cell- Based Noninvasive Prenatal Testing (NIPT): Single Cell Prenatal Diagnosis (SCPD)
NCT05076734 ·Status: COMPLETED ·Phase: NA
-
Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: "Expect With Me"
NCT02169024 ·Status: COMPLETED ·Phase: NA
-
Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study)
NCT01693666 ·Status: COMPLETED ·Phase: NA
-
Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia
NCT00583635 ·Status: COMPLETED
-
A Modernized Approach to Prenatal Care in Low Risk Women
NCT01606774 ·Status: COMPLETED ·Phase: NA
-
Phase I Study of Nicotinamide for Early Onset Preeclampsia
NCT02213094 ·Status: COMPLETED ·Phase: PHASE1
-
Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth
NCT02560246 ·Status: COMPLETED
-
Promoting Healthy Brain Development: Wellness for 2 Study
NCT05052281 ·Status: COMPLETED ·Phase: NA
-
Fresh RX: NHS 2020
NCT04845230 ·Status: RECRUITING ·Phase: NA
-
The Effect of Steroids on Maternal Glucose Levels
NCT03021837 ·Status: COMPLETED
-
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
NCT05739123 ·Status: RECRUITING
-
Singapore PREconception Study of Long-Term Maternal and Child Outcomes
NCT03531658 ·Status: ACTIVE_NOT_RECRUITING
-
Evolocumab Pregnancy Exposure Registry
NCT02957604 ·Status: TERMINATED
-
BMI-based Vitamins in Obese Pregnant Women
NCT02802566 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Growing Up in Singapore Towards Healthy Outcomes
NCT01174875 ·Status: ACTIVE_NOT_RECRUITING
-
Developing & Evaluating Models for Early Predicting Obstetrical Diseases in Pregnant Women by Non-invasive Prenatal Test
NCT06385366 ·Status: ENROLLING_BY_INVITATION
-
Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes
NCT04633551 ·Status: COMPLETED ·Phase: NA
-
Repeat Antenatal Corticosteroids
NCT03133104 ·Status: COMPLETED
-
Personalized Nutrition During Pregnancy
NCT07508709 ·Status: WITHDRAWN ·Phase: NA
-
The Effect of Zinc, β-carotene, and Vitamin D3 in Preterm Delivery Through Placental MyD88, TRIF, NFkB, and IL-1β
NCT03005496 ·Status: COMPLETED ·Phase: PHASE4
-
The MOM-CARE Trial : Evaluating Antenatal and Postnatal MMSPlus for Improved Infant Birth and Growth Outcomes
NCT07029282 ·Status: RECRUITING ·Phase: PHASE3
-
Infection and Adverse Pregnancy Outcome
NCT02673216 ·Status: UNKNOWN
-
Prenatal Nutrient Status Study
NCT06156826 ·Status: COMPLETED
-
Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss
NCT04621773 ·Status: UNKNOWN